Utah Medical Products, Inc. Announces Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / May 5, 2026 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty-one cents ($.31) per share of common stock payable on July 3, 2026 to stockholders of record at the close of business on June 17, 2026. This is a 1.6% increase over the dividend declared in the same quarter of the prior year.

Accesswire • May 5, 2026

Utah Medical's Q1 Earnings Fall Y/Y Due to Elevated Litigation Costs

UTMD reports a year-over-year decline in Q1 earnings per share and sales, pressured by lost distributor business and higher costs, despite improved margins and a strong balance sheet.

Zacks Investment Research • Apr 29, 2026

Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026

SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its previously announced projections for calendar year 2026. But because of the relatively short span of time, results for any given three-month period in comparison with a previous three-month period may not be indicative of comparative results for the year as a whole.

Accesswire • Apr 23, 2026

Utah Medical Gains 32% in a Year: Should You Buy the Stock?

UTMD's niche leadership, global footprint, and strong cash generation position it to benefit from rising demand for high-quality maternal and neonatal healthcare solutions.

Zacks Investment Research • Apr 16, 2026

The Zacks Analyst Blog American Express, Intuitive Surgical, Shopify and Utah Medical Products

American Express leads featured reports as spending growth and digital investments drive gains, while Intuitive Surgical and Shopify show mixed momentum.

Zacks Investment Research • Apr 2, 2026

Utah Medical's Q4 Earnings Hurt by OEM Decline, Fall Y/Y

UTMD's Q4 earnings fall year over year due to weak OEM sales and lower international Filshie sales, but strong U.S. Filshie growth and steady margins help offset broader revenue pressure.

Zacks Investment Research • Feb 4, 2026

Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend

SALT LAKE CITY, UT / ACCESS Newswire / November 4, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Kevin C. Timken, Esq to its Board of Directors.

Accesswire • Nov 4, 2025

UTMD's Q3 Earnings Dip Y/Y on Trade Disruptions, Margins Squeeze

Utah Medical's Q3 earnings fell 20% year over year as order cancellations and tariffs pressured margins. Growth in U.S. Filshie devices and direct sales helped partially offset declines.

Zacks Investment Research • Oct 29, 2025

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025

SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2025 financial results that were unusually hampered by global trade uncertainty. Currencies in this release are denoted as $ or USD = U.S. Dollars; AUD = Australia Dollars; £ or GBP = UK Pound Sterling; C$ or CAD = Canadian Dollars; and € or EUR = Euros.

Accesswire • Oct 23, 2025

UTMD's Q2 Earnings Slip Y/Y Due to Falling OEM Sales, Stock Down 3%

Utah Medical's Q2 earnings decrease year over year on lower OEM sales and weak international demand, though cost controls helped cushion margins.

Zacks Investment Research • Jul 30, 2025